Related Experiment Video
Updated: Aug 28, 2026

High Content Screening Analysis to Evaluate the Toxicological Effects of Harmful and Potentially Harmful Constituents (HPHC)
Published on: May 10, 2016
Age-specific and age-adjusted penetrance as poison center outcome measures
W R Wolowich1, M J Casavant, C A Fisher
1Central Ohio Poison Center, Children's Hospital, Ohio State University, Columbus, USA. wolowicb@chi.osu.edu
Background:
The American Association of Poison Control Centers defines penetrance as the number of exposures per 1000 residents of a population during one year. This metric fails to account for confounding by age group variability. We demonstrate the error caused by using raw penetrance and present two alternate methods of calculation, age-specific penetrance and age-adjusted penetrance.
Methods:
Data from the toxic exposure surveillance system were collected from calls to our 41 county regional poison centers in 1998. Age-specific penetrance (ASP) was calculated by dividing the number of exposures (E) in age interval "i" in county "A" by 1000 population in age interval "Pi" in county "A" or ASP = Ei/Pi. AAP is the summation of the weighted age-specific penetrance. Weights (w(si)) represent the relative age distribution of a standard population, in this case the 1998 US population. AAP = sigma(i) w(si) * Ei/Pi.
Results:
[table: see text] County C has low raw penetrance and is known to have relatively fewer toddlers and presumably a lower incidence of poisoning. This demonstrates that raw penetrance misrepresents populations with small proportions of children and should not be used to compare promotion or prevention activities between populations.
Conclusion:
We recommend poison centers and the American Association of Poison Control Centers replace raw penetrance with age-adjusted penetrance as one measure of the effectiveness of a poison center's awareness efforts.
Related Concept Videos
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption
Pharmacodynamics in Geriatric Patients: Effects of Age
Pharmacokinetics in Pediatric Patients: Drug Metabolism
Pharmacokinetics in Pediatric Patients: Drug Excretion
Drug Toxicity: Risk factors
Pharmaceutical Poisoning: Potential Scenarios
